Addiction Toxicology Case Conference - August 2024

Timothy J. Wiegand, MD, FACMT, FAACT, DFASAM is an Associate Professor of Emergency Medicine and Public Health Sciences at the University of Rochester Medical Center (URMC) in Rochester, New York. Board-certified in both Medical Toxicology and Addiction Medicine, Dr. Wiegand specializes in Addiction Toxicology, combining clinical practice with research, teaching, and leadership roles. He has served two terms on the Board of Directors for the American College of Medical Toxicology (ACMT) and is currently on the Board of Directors for the American Society of Addiction Medicine (ASAM). In 2023, he began a two-year term as Treasurer of ASAM, having previously served as Vice President on the Executive Council. Dr. Wiegand founded and led the Toxicology Service at URMC until 2022, when he transitioned to Director of Addiction Medicine and Director of Addiction Medicine Consults in the Department of Emergency Medicine. He also serves as Fellowship Director for the URMC Combined Addiction Medicine Fellowship and is leading efforts to launch the URMC Medical Toxicology Fellowship, which is expected to be formally accredited by July 2023.

Since 1986, Gloria Baciewicz has specialized in the treatment of addiction. Professor of clinical psychiatry at the University of Rochester Medical Center, she serves as an addiction psychiatrist at Strong Recovery. Dr. Baciewicz is certified in addiction medicine by the American Board of Preventive Medicine and board certified in psychiatry, with added qualifications in addiction psychiatry. Dr. Baciewicz is a co-principal investigator for the University of Rochester’s Recovery Center of Excellence.

Dr. Aldy initially joined the Toxicology Investigators Consortium with the American College of Medical Toxicology as the first ToxIC intern, where she led a vaping initiative around the country. In her new position with ToxIC, Dr. Aldy is responsible for the day to day management of the ToxIC program, staff and site coordination, helping with research projects and publications, and acquiring support for ToxIC through grants and related activities.

Dr. Aldy earned her medical degree at the University of North Texas Health Science Center in Fort Worth, Texas. During her medical school training, she concurrently applied and enrolled in an MBA program with concentration in Health Management at the University of North Texas which she attained shortly after starting residency. She completed an emergency medicine residency at Western Michigan University in Kalamazoo, Michigan. She attended her Medical Toxicology Fellowship at University of Texas at Southwestern Medical Center in Dallas, Texas. 

Dr. Aldy has an academic and clinical affiliation within the departments of Emergency Medicine and Medical Toxicology at the Baylor University Medical Center in Dallas, Texas.

Jeffrey Brent, M.D., Ph.D., is a Distinguished Clinical Professor of Medicine (Pulmonary and Critical Care Medicine) and Emergency Medicine at the University of Colorado Schools of Medicine and Public Health. He did his fellowship in medical toxicology at the Rocky Mountain Poison and Drug Center, where he has been both medical director and fellowship director. He is a former President of the American Academy of Clinical Toxicology and a former Board member of the American College of Medical Toxicology. Dr. Brent is the senior editor of Critical Care Toxicology: the Diagnosis and Management of the Critically Poisoned Patient, currently in its second edition. Dr. Brent is Co-Principal Investigator of ACMT’s Toxicology Investigators Consortium.

Dr. Alex Krotulski serves as an Associate Director at CFSRE working in the areas of forensic toxicology and forensic chemistry and is the Program Manager for NPS Discovery. Dr. Krotulski holds faculty appointment and serves as the Assistance Program Director for the Thomas Jefferson University Master of Science in Forensic Toxicology (MSFT) program and was recently appointed as an Associate Editor for the Journal of Analytical Toxicology. Dr. Krotulski received his Doctor of Philosophy degree in Analytical Chemistry from Temple University in 2019 following receipt of his Master of Science degree in Forensic Science from Arcadia University in 2015 and Bachelor of Science in Chemistry from Loyola University New Orleans in 2013.

Dr. Barry Logan is Sr. vice president of Forensic Sciences, and Chief Scientist for NMS Labs. He is also Executive Director at the non-profit Center for Forensic Science Research and Education (CFSRE) at the Fredric Rieders Family Foundation in Willow Grove, Pennsylvania. 

Dr. Logan is a Fellow of the American Board of Forensic Toxicologists (ABFT), and has over 190 publications in forensic toxicology and chemistry, including work on the effects of illicit and prescription drugs on drivers, and drug caused and related death. His current research priorities are focused on new drug surveillance and trends, the polydrug crisis, and the analytical and interpretive toxicology and chemistry of novel psychoactive substances, founding www.NPSDiscovery.org in 2018.

Dr. Logan’s has academic appointments at Indiana University, Arcadia University and Thomas Jefferson University in Philadelphia. He serves on the Advisory Board for NIDA’s National Drug Early Warning System (NDEWS). In recognition of his work and contributions, Dr. Logan received TIAFT’s Alan Curry Award in 2022, and is a past President of the American Academy of Forensic Sciences (AAFS).

Dr. Wax is the Executive Director of the American College of Medical Toxicology. He received his B.A from Dartmouth College, his M.D. from the Mount Sinai School of Medicine, his Emergency Medicine training at the UCLA Hospitals, and his Medical Toxicology training at Bellevue Medicine Center / New York University. He is Board-certified in both Medical Toxicology and Emergency Medicine, and is a Fellow of the American College of Medical Toxicology.